Main menu

One solution — from R&D, to QC

Identity, integrity, and hidden risks, all in one view.

Target Discovery

Preclinical

Analytical Development

Manufacturing & QC

Cell and gene therapy development presents significant complexity. Next-generation sequencing (NGS) is essential as a critical quality control (QC) checkpoint throughout development — helping ensure product consistency, efficacy, and safety.


Brochure: biopharma CGT — 2 pages

Cell and gene guide

Learn how our sequencing technology delivers ultra-rich, multiomic data for comprehensive insights. Resolve complex questions fast with simple solutions driven by data.


Don't take our word for it

Application of nanopore long-read sequencing to sterility testing for cell therapy products

Breaking barriers in cell & gene therapy

Recent publications


Accuracy you can trust — insights you can act on

Long reads spanning entire plasmids and AAV genomes reveal structure, orientation, and sequence continuity — helping teams understand not only what’s present, but how it may behave within complex therapeutic systems.


Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Modern slavery policy Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
English flag